KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Change in Cash (2017 - 2025)

Historic Change in Cash for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$497000.0.

  • Bionano Genomics' Change in Cash rose 9606.77% to -$497000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year increase of 7622.02%. This contributed to the annual value of -$8.8 million for FY2024, which is 16825.08% down from last year.
  • As of Q3 2025, Bionano Genomics' Change in Cash stood at -$497000.0, which was up 9606.77% from -$63000.0 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Change in Cash ranged from a high of $323.6 million in Q1 2021 and a low of -$191.8 million during Q3 2021
  • In the last 5 years, Bionano Genomics' Change in Cash had a median value of -$523000.0 in 2022 and averaged -$1.9 million.
  • Data for Bionano Genomics' Change in Cash shows a peak YoY increase of 363014.07% (in 2021) and a maximum YoY decrease of 1156551.11% (in 2021) over the last 5 years.
  • Bionano Genomics' Change in Cash (Quarter) stood at -$116.2 million in 2021, then surged by 80.48% to -$22.7 million in 2022, then increased by 26.7% to -$16.6 million in 2023, then skyrocketed by 102.28% to $379000.0 in 2024, then tumbled by 231.13% to -$497000.0 in 2025.
  • Its Change in Cash stands at -$497000.0 for Q3 2025, versus -$63000.0 for Q2 2025 and -$5.9 million for Q1 2025.